We are monitoring the impact of COVID-19 on Europe Thin Film Drugs Market Get in touch with us for detailed analysis Know More
Share on

Europe Thin Film Drugs Market Research Report - Segmented By Product, Disease Indication, Distribution Channel & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 6194
Pages: 145

Europe Thin Film Drugs Market Size & Growth (2022 to 2027):

As per the research report, the size of the Europe Thin Film Drugs market is valued at USD 5.18 billion in 2022 and is expected to reach USD 8.09 billion by 2027 at 9.33% CAGR during the forecast period 2022 to 2027.

The European thin-film drugs market is developing robust business strategies, aiming to influence various users and customers, primarily driving the market. Thin-film drugs are emerged as an alternative to tablets or capsules due to their improved efficacy. The drugs are made from polymers that dissolve quickly when held in the mouth or oral cavity, delivering the drug directly into the body's systemic circulation, especially by sublingual absorption. The bioavailability of a sublingually administered dose is around 35%, with the onset of reaction in 5-10 mins. All these factors increase the popularity of thin film drugs in the pharmaceutical industry.

Oral thin-film drugs provide high patient compliance ease of storage and transport. In addition, they offer precise dosing with the desired effective result. Thus, the thin film drug delivery systems market has been substantially attractive for the past several years. The high level of acceptance and the impressive benefits have further boosted the European thin films drugs market.

Coupled with effective customer-centric strategies will increase the volume of consumers. Furthermore, drivers such as growing demand for efficient drug delivery systems, low cost of manufacturing thin film drugs compared to traditional dosage forms, and increased research to develop new polymeric thin films are predicted to increase the demand for the European market.

In addition, beneficial government initiatives and an increase in the number of pharmaceutical companies are other drivers expected to increase the growth of the Europe thin film drugs market.

However, the European thin film drugs market will be negatively impacted by the high costs of treatment, availability of various alternative drug delivery options, and lack of awareness. In addition, some of the solvents and polymers used in film coating are relatively harmful. Inflammation due to some of the organic solvents used as vehicles for film-forming polymers could present a risk to the patient.

This research report on the Europe Thin Film Drugs Market has been segmented and sub-segmented into the following categories:

By Product:

  • Oral Thin Film
  • Transdermal Thin Film

By Disease Indication:

  • Schizophrenia, Migraine
  • Opioid Dependence
  • Nausea and Vomiting

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Store
  • Retail Pharmacies
  • E-Commerce

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the German thin film drugs market is anticipated to grow by around 6.2% CAGR during the forecast period. The presence of a large population of geriatric patients with dysphagia and the increase in healthcare spending will help drive the market in Germany in the coming years. In 2015, just over 4.65 million people in Germany were at least 80 years old. Their number will continue to grow over the next decades and reach around 9.97 million by 2050; this corresponds to a population share of about 13%.

The Spain thin film drugs market is expected to be a lucrative market for thin films drugs during the mentioned period. And the France thin film drugs market is leading the market in the improving awareness, production, and distribution of oral thin-film drugs, which will also help the progress of the Europe thin film drugs market. Furthermore, a large population of geriatric patients focuses on providing other drug delivery options, especially for critical drugs, and more clinical trials in laboratories, medical institutes, and research centers in these countries drive the market in the coming years.

The U.K thin film drugs market accounted for over 55% due to owing to the presence of advanced technologies for pharmaceutical research and development, high investment for the discovery of new drug delivery techniques, and the increasing need for effective drug delivery routes and their stability would further stimulate the market for thin film drugs in Europe.

KEY MARKET PLAYERS

Key players operating in the Europe Thin Film Drugs Market profiled in this report are Pfizer Inc, Wolters Kluwer, Solvay, Allergan plc., MonoSol Rx, IntelGenx Corp., ZIM Laboratories Limited, and IntelGenx Corp, Sumitomo Dainippon Pharma Co. Ltd., Indivior Plc, Novartis AG.,

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods     

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Oral Thin Film         

                                                5.1.2.1 Sublingual Film

                                                5.1.2.2 Fully Dissolving Dental/Buccal Film

                                5.1.3 Transdermal Thin Film        

                                5.1.4 Y-o-Y Growth Analysis, By Product               

                                5.1.5 Market Attractiveness Analysis, By Product             

                                5.1.6 Market Share Analysis, By Product               

                5.2 Disease Indication                   

                                5.2.1 Introduction           

                                5.2.2 Schizophrenia        

                                5.2.3 Migraine  

                                5.2.4 Opioid Dependence            

                                5.2.5 Nausea and Vomiting         

                                5.2.6 Y-o-Y Growth Analysis, By Disease Indication           

                                5.2.7 Market Attractiveness Analysis, By Disease Indication         

                                5.2.8 Market Share Analysis, By Disease Indication          

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Drug Store               

                                5.3.4 Retail Pharmacies

                                5.3.5 E-Commerce          

                                5.3.6 Others      

                                5.3.7 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.8  Market Attractiveness Analysis, By Distribution Channel   

                                5.3.9  Market Share Analysis, By Distribution Channel     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Disease Indication

                                                6.1.3.4 By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Disease Indication

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Disease Indication

                                                6.1.5.4 By Distribution Channel

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis AG                

                8.3 Wolters Kluwer                         

                8.4 Solvay                           

                8.5 Allergan plc.                               

                8.6 Sumitomo Dainippon Pharma Co. Ltd.                            

                8.7 Indivior Plc.                 

                8.8 MonoSol Rx                

                8.9 IntelGenx Corp.                        

                8.10 ZIM Laboratories Limited                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  2. Europe Oral Thin Film Market By Region, From 2022 to 2027 ( USD Billion )
  3. Europe Transdermal Thin Film Market By Region, From 2022 to 2027 ( USD Billion )
  4. Europe Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  5. Europe Schizophrenia Market By Region, From 2022 to 2027 ( USD Billion )
  6. Europe Migraine Market By Region, From 2022 to 2027 ( USD Billion )
  7. Europe Opioid Dependence Market By Region, From 2022 to 2027 ( USD Billion )
  8. Europe Nausea and Vomiting Market By Region, From 2022 to 2027 ( USD Billion )
  9. Europe Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  10. Europe Hospital Pharmacies Market By Region, From 2022 to 2027 ( USD Billion )
  11. Europe Drug Store Market By Region, From 2022 to 2027 ( USD Billion )
  12. Europe Retail Pharmacies  Market By Region, From 2022 to 2027 ( USD Billion )
  13. Europe E-Commerce Market By Region, From 2022 to 2027 ( USD Billion )
  14. U.K. Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  15. U.K. Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  16. U.K. Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  17. Germany Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  18. Germany Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  19. Germany Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  20. France Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  21. France Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  22. France Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  23. Italy Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  24. Italy Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  25. Italy Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  26. Spain Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  27. Spain Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  28. Spain Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample